久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Teva settles California’s pay-for-delay allegations pharmaceutical-technology
    August 01, 2019
    Drug companies Teva Pharmaceutical, Endo Pharmaceuticals and Teikoku Pharma have signed four settlement agreements with the State of California to resolve allegations regarding pay-for-delay deals to prevent cheaper, generic medicines from entering the ma
  • Mylan Agrees to Pay $465 Million for Underpaying EpiPen Rebates americanpharmaceuticalreview
    August 21, 2017
    Mylan Inc. and Mylan Specialty L.P. have agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen?as a generic drug to avoid paying rebates owed primarily to Medicaid, the Justice Department a
PharmaSources Customer Service